Journal of Cervical Cancer publishes original research, systematic reviews, clinical studies, translational work, and public health analyses that advance cervical cancer prevention, diagnosis, and treatment.

Submissions should clearly align with cervical cancer outcomes, HPV related disease, screening, or care delivery. Manuscripts focused on unrelated gynecologic topics without cervical relevance may be redirected.

Prepare manuscripts with a clear abstract, introduction, methods, results, and discussion. Highlight clinical relevance, patient impact, and limitations.

Include a concise title, structured abstract, and keywords that support discoverability across clinical and public health databases.

Follow appropriate reporting standards such as CONSORT, STROBE, or PRISMA when relevant. Provide enough detail for replication and critical appraisal.

For diagnostic or biomarker studies, report sensitivity, specificity, and validation metrics. For clinical trials, include registration numbers and protocol references.

All research involving human participants must include institutional review board approval and informed consent documentation. Provide the ethics committee name and approval number.

Clinical trials should be registered in a public registry prior to enrollment and include registration identifiers in the manuscript.

Authors are encouraged to deposit datasets, code, and supplemental materials in trusted repositories. Provide persistent links or accession numbers within the manuscript.

If data cannot be shared due to privacy or regulatory constraints, include a clear justification and describe how qualified researchers may request access.

Provide high resolution figures with descriptive captions. Tables should be editable and placed near the first citation in the text.

Supplementary files may include protocols, analytic scripts, or extended data tables. Ensure all supplementary content is referenced in the manuscript.

Use consistent citation formatting and verify references for accuracy. Include DOIs where available and ensure citations support key claims.

Define abbreviations on first use and maintain consistent terminology throughout the manuscript.

Authors may submit through ManuscriptZone or the Simple Submission Form. Both routes are reviewed by the same editorial team and follow the same peer review process.

Upload the main manuscript, figures, tables, and any required ethical or trial documentation. Provide a cover letter explaining scope alignment and significance.

Following acceptance, manuscripts undergo copyediting, formatting, and author proof review. Authors are asked to confirm final accuracy before publication.

APC invoices are issued after acceptance. Publication proceeds after payment confirmation or approved waivers.

Provide detailed HPV testing methods, including assay type, target genes, and quality control procedures. If multiple assays are used, explain comparability and thresholds to support interpretation across populations.

For imaging or colposcopy studies, describe equipment settings, operator training, and inter rater reliability where applicable. Include image selection criteria and any automated scoring pipelines used for assessment.

Clinical staging should follow accepted guidelines and specify version or year. Include information on tumor histology, grading, and margin status when relevant to treatment or prognosis.

Report treatment protocols with sufficient detail to enable replication, including radiation dose schedules, surgical technique, or chemotherapy regimens. Describe supportive care practices that may influence outcomes.

If adverse events are monitored, describe classification systems used and provide a clear summary of safety outcomes. Include reporting timelines and any protocol defined stopping rules when applicable.

For screening studies, specify screening intervals, follow up pathways, and loss to follow up handling. Explain triage pathways from abnormal results to diagnostic confirmation.

Public health or implementation studies should describe context, population characteristics, and program funding structures to support interpretation. Clarify workforce training and community engagement approaches.

Statistical analysis plans should include handling of missing data, adjustment variables, and sensitivity analyses. Provide justification for model selection and report effect sizes with confidence intervals.

When using machine learning or predictive models, include training and validation splits, performance metrics, and model interpretability summaries. Describe steps taken to reduce bias and ensure generalizability.

For biomarker studies, provide sample processing steps, assay calibration, and validation cohorts. Include information on batch effects and quality control thresholds.

Describe patient consent language for data sharing and de identification practices when datasets are archived. If access is restricted, include instructions for qualified requests.

If preprints are available, provide the DOI or repository link and disclose any substantive changes made during peer review or revision.

Provide a brief statement on how findings may influence clinical guidelines or prevention strategy. Link conclusions directly to evidence within the results section.

Highlight equity considerations, including representation of diverse populations and access to screening or treatment. Discuss implications for underserved groups when possible.

Include author contribution statements, funding disclosures, and conflict of interest declarations in a dedicated section. Transparency supports trust and accountability.

For multicenter studies, describe harmonized protocols, data governance, and quality assurance steps across sites to ensure consistent reporting and ethical compliance.

Provide details on sample handling and storage conditions, especially for tissue, cytology, or blood based biomarkers, so results can be compared across laboratories.

For surgical series, include perioperative care protocols, complication grading, and follow up intervals to support comparability across care settings.

If using patient reported instruments, note validation status, language adaptations, and scoring methodology to ensure interpretability.

Describe how missing follow up or attrition was handled in longitudinal cohorts, including sensitivity analyses for potential bias.

For registry based studies, clarify data linkage procedures, coverage periods, and any limitations in case ascertainment.

For imaging studies, report reader training, calibration exercises, and diagnostic thresholds so results can be compared across settings.

For pathology or histology workflows, specify staining protocols, scoring systems, and inter observer agreement when relevant.

Include follow up duration and recurrence definitions for outcome measures. When comparing interventions, specify equivalence or noninferiority margins if applicable.

For vaccine effectiveness studies, report coverage estimates, dosing schedules, and verification methods used to confirm vaccination status.

Describe laboratory quality assurance steps, including control samples and repeat testing procedures, to support reproducibility consistently across sites.

Cervical cancer research benefits from clear reporting of population characteristics, including age distribution, screening history, and vaccination status. This context helps readers interpret generalizability and informs policy decisions.

When describing interventions, explain how they align with clinical guidelines or public health recommendations. Contextualizing findings supports translation into care pathways.

Transparent reporting of funding sources and resource constraints helps readers assess feasibility in different settings. This is critical for global health adoption.

Where possible, include discussion of equity impacts and strategies to reduce disparities in screening or treatment access.

High quality visual summaries and clear tables improve uptake by clinicians and program managers. Provide succinct interpretations for key outputs.

Consider including patient engagement or community involvement approaches when they inform program design or trial recruitment.

Explain how results compare with prior evidence and identify remaining knowledge gaps for future cervical cancer research.

Ensure terminology is consistent and define acronyms on first use to improve clarity for interdisciplinary audiences.

Discuss potential implications for implementation in low and middle income settings where cervical cancer burden remains high.

The editorial office can advise on scope fit and reporting expectations before submission at [email protected].

Journal of Cervical Cancer is dedicated to advancing cervical cancer prevention, diagnosis, and treatment through transparent publishing.

Our editorial office supports authors, reviewers, and readers with clear guidance and responsive communication. Contact [email protected] for scope or workflow questions.